Spineguard
SpineGuard SA provides designs, develops, and markets medical devices for spine in France and internationally. The company offers PediGuard drilling instruments comprising straight, curved, cannulated, psifguard, and threaded PediGuard products; and DSG smart screw that allows for one step screw placement treatment. It also provides DSG (Dynamic Surgical Guidance) Connect app that allows collecti… Read more
Spineguard (ALSGD) - Net Assets
Latest net assets as of June 2025: €4.28 Million EUR
Based on the latest financial reports, Spineguard (ALSGD) has net assets worth €4.28 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.35 Million) and total liabilities (€4.07 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €4.28 Million |
| % of Total Assets | 51.3% |
| Annual Growth Rate | -3.76% |
| 5-Year Change | N/A |
| 10-Year Change | -17.56% |
| Growth Volatility | 51.48 |
Spineguard - Net Assets Trend (2010–2024)
This chart illustrates how Spineguard's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Spineguard (2010–2024)
The table below shows the annual net assets of Spineguard from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €3.90 Million | -35.28% |
| 2023-12-31 | €6.03 Million | +17.33% |
| 2022-12-31 | €5.14 Million | +1.81% |
| 2021-12-31 | €5.05 Million | +56660.13% |
| 2020-12-31 | €-8.93K | -101.51% |
| 2019-12-31 | €592.03K | +220.93% |
| 2018-12-31 | €-489.56K | -134.81% |
| 2017-12-31 | €-208.50K | -117.52% |
| 2016-12-31 | €1.19 Million | -74.87% |
| 2015-12-31 | €4.73 Million | -17.90% |
| 2014-12-31 | €5.77 Million | -35.31% |
| 2013-12-31 | €8.92 Million | +67.66% |
| 2012-12-31 | €5.32 Million | -25.60% |
| 2011-12-31 | €7.15 Million | +7.09% |
| 2010-12-31 | €6.67 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Spineguard's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 87674300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €2.68 Million | 68.53% |
| Other Comprehensive Income | €-34.79 Million | -891.11% |
| Other Components | €39.10 Million | 1001.53% |
| Total Equity | €3.90 Million | 100.00% |
Spineguard Competitors by Market Cap
The table below lists competitors of Spineguard ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Megado Minerals Ltd
AU:MEG
|
$5.70 Million |
|
Tintra PLC
PINK:TNTAF
|
$5.70 Million |
|
ALPINA HOLDINGS
F:B0M
|
$5.70 Million |
|
LOCKHEED MARTIN - Dusseldorf Stock Exchang
DU:LOM
|
$5.70 Million |
|
Feelux Co. Ltd.
KO:033180
|
$5.70 Million |
|
Admiralty Resources NL
AU:ADY
|
$5.70 Million |
|
Yen Bai Industry Mineral JSC
VN:YBM
|
$5.70 Million |
|
Gaya Abadi Sempurna
JK:SLIS
|
$5.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Spineguard's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,031,947 to 3,903,687, a change of -2,128,260 (-35.3%).
- Net loss of 3,082,000 reduced equity.
- Share repurchases of 701,110 reduced equity.
- New share issuances of 705,013 increased equity.
- Other comprehensive income decreased equity by 34,554,611.
- Other factors increased equity by 35,504,448.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-3.08 Million | -78.95% |
| Share Repurchases | €701.11K | -17.96% |
| Share Issuances | €705.01K | +18.06% |
| Other Comprehensive Income | €-34.55 Million | -885.18% |
| Other Changes | €35.50 Million | +909.51% |
| Total Change | €- | -35.28% |
Book Value vs Market Value Analysis
This analysis compares Spineguard's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.48x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.04x to 1.48x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | €2.80 | €0.12 | x |
| 2012-12-31 | €1.76 | €0.12 | x |
| 2013-12-31 | €2.26 | €0.12 | x |
| 2014-12-31 | €1.32 | €0.12 | x |
| 2015-12-31 | €1.00 | €0.12 | x |
| 2016-12-31 | €0.24 | €0.12 | x |
| 2017-12-31 | €-0.04 | €0.12 | x |
| 2018-12-31 | €-0.08 | €0.12 | x |
| 2019-12-31 | €0.06 | €0.12 | x |
| 2020-12-31 | €0.00 | €0.12 | x |
| 2021-12-31 | €0.18 | €0.12 | x |
| 2022-12-31 | €0.16 | €0.12 | x |
| 2023-12-31 | €0.16 | €0.12 | x |
| 2024-12-31 | €0.08 | €0.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Spineguard utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -78.95%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -66.31%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 2.11x
- Recent ROE (-78.95%) is below the historical average (-70.95%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -35.92% | -85.47% | 0.36x | 1.16x | €-3.28 Million |
| 2012 | -61.42% | -84.23% | 0.48x | 1.52x | €-3.80 Million |
| 2013 | -39.42% | -76.16% | 0.37x | 1.39x | €-4.41 Million |
| 2014 | -78.70% | -104.08% | 0.51x | 1.48x | €-5.12 Million |
| 2015 | -81.90% | -62.26% | 0.63x | 2.09x | €-4.35 Million |
| 2016 | -351.13% | -55.98% | 0.79x | 7.91x | €-4.30 Million |
| 2017 | 0.00% | -50.47% | 1.00x | 0.00x | €-4.10 Million |
| 2018 | 0.00% | -30.81% | 0.96x | 0.00x | €-2.29 Million |
| 2019 | -115.83% | -10.04% | 0.80x | 14.35x | €-744.93K |
| 2020 | 0.00% | -55.99% | 0.60x | 0.00x | €-2.72 Million |
| 2021 | -34.16% | -39.15% | 0.37x | 2.36x | €-2.23 Million |
| 2022 | -46.55% | -42.74% | 0.49x | 2.24x | €-2.91 Million |
| 2023 | -69.35% | -97.00% | 0.39x | 1.83x | €-4.79 Million |
| 2024 | -78.95% | -66.31% | 0.56x | 2.11x | €-3.47 Million |
Industry Comparison
This section compares Spineguard's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $36,532,206
- Average return on equity (ROE) among peers: -28.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Spineguard (ALSGD) | €4.28 Million | -35.92% | 0.95x | $5.70 Million |
| Affluent Medical SAS (AFME) | $33.83 Million | -45.01% | 0.77x | $31.64 Million |
| Biosynex (ALBIO) | $124.31 Million | -29.72% | 0.94x | $7.06 Million |
| Bluelinea SA (ALBLU) | $1.96 Million | -41.72% | 0.71x | $6.02 Million |
| Carmat (ALCAR) | $-43.76 Million | 0.00% | 0.00x | $3.28 Million |
| Diagnostic Medical Systems SA (ALDMS) | $13.72 Million | -36.04% | 2.73x | $13.39 Million |
| Eurobio Scientific SA (ALERS) | $175.17 Million | 2.76% | 0.81x | $5.52 Million |
| Ikonisys SA (ALIKO) | $20.01 Million | -2.85% | 0.13x | $9.76 Million |
| Implanet SA (ALIMP) | $3.54 Million | -99.97% | 3.09x | $6.96 Million |
| Mediantechn (ALMDT) | $0.00 | 0.00% | 0.00x | $86.92 Million |